Alnylam Pharmaceuticals Reports Net Income In Q4

(RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) reported fourth quarter net income of $111.5 million compared to a loss of $83.8 million, prior year. GAAP net income per common share was $0.82 compared to a loss of $0.65. Non-GAAP net income per share increased to $1.25 from $0.06.

Fourth quarter total revenues were $1.10 billion compared to $593.17 million, prior year. Total net product revenues were $994.7 million compared to $450.8 million.

For 2026, the company projects total net product revenues in a range of $4.9 billion - $5.3 billion.

In pre-market trading on NasdaqGS, Alnylam shares are down 2.1 percent to $315.00.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.